The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Gottenberg, J.-E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510837103 · Cited by 611
Self-citationTheander, E., Henriksson, G., Ljungberg, O., Mandl, T., Manthorpe, R., & Jacobsson, L. T. H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041186 · Cited by 574
Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study
Pijpe, J., van Imhoff, G. W., Spijkervet, F. K. L., Roodenburg, J. L. N., Wolbink, G. J., Mansour, K., Vissink, A., Kallenberg, C. G. M., & Bootsma, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21260 · Cited by 500
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
Gottenberg, J.-E., Guillevin, L., Lambotte, O., Combe, B., Allanore, Y., Cantagrel, A., Larroche, C., Soubrier, M., Bouillet, L., Dougados, M., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029694 · Cited by 401
Self-citationMonoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20
Sansonno, D., De Re, V., Lauletta, G., Tucci, F. A., Boiocchi, M., & Dammacco, F. (2003) · Blood · doi:10.1182/blood-2002-10-3162 · Cited by 370
Bohnhorst, J. Ø., Bjørgan, M. B., Thoen, J. E., Natvig, J. B., & Thompson, K. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3610 · Cited by 321
Cambridge, G., Stohl, W., Leandro, M. J., Migone, T., Hilbert, D. M., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21650 · Cited by 274
Lavie, F., Miceli‐Richard, C., Quillard, J., Roux, S., Leclerc, P., & Mariette, X. (2004) · The Journal of Pathology · doi:10.1002/path.1533 · Cited by 193
Self-citationRituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future
Sfikakis, P. P., Boletis, J., & Tsokos, G. C. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000172798.26249.fc · Cited by 153
Pijpe, J., van Imhoff, G. W., Vissink, A., van der Wal, J. E., Kluin, P. M., Spijkervet, F. K. L., Kallenberg, C. G. M., & Bootsma, H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030684 · Cited by 103
Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab)
D'Arcy, C. A., & Mannik, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1717::aid-art299>3.0.co;2-c · Cited by 96
Successful treatment of refractory anterior scleritis in primary Sjögren's syndrome with rituximab
Ahmadi-Simab, K., Lamprecht, P., Nölle, B., Ai, M., & Gross, W. L. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.027128 · Cited by 95
Gottenberg, J. E., Busson, M., Cohen-Solal, J. F. G., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030643 · Cited by 83
Self-citationDelayed-type hypersensitivity reaction or serum sickness after rituximab treatment
Hellerstedt, B. A., & Ahmed, A. A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg488 · Cited by 69
Beum, P. V., Kennedy, A. D., & Taylor, R. P. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.03.012 · Cited by 54
Cited by
Seror, R., Ravaud, P., Bowman, S. J., Baron, G., Tzioufas, A., Theander, E., Gottenberg, J.-E., Bootsma, H., Mariette, X., & Vitali, C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.110619 · Cited by 965
Self-citationEULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216114 · Cited by 732
Self-citationUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Terrier, B., Amoura, Z., Ravaud, P., Hachulla, E., Jouenne, R., Combe, B., Bonnet, C., Cacoub, P., Cantagrel, A., De Bandt, M., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27541 · Cited by 411
Self-citationAdvances in understanding the pathogenesis of primary Sjögren's syndrome
Nocturne, G., & Mariette, X. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.110 · Cited by 404
Self-citation
Metadata
- Authors
- Seror, R., Sordet, C., Guillevin, L., Hachulla, E., Masson, C., Ittah, M., Candon, S., Le Guern, V., Aouba, A., Sibilia, J., Gottenberg, J.-E., & Mariette, X.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 66
- Issue
- 3
- Pages
- 351-357
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2154059578
- Cited by
- 305
- References
- 18
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.